http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
- 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
- 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
RISS 인기검색어
- 검색키워드
- 저자 : ( Hong Jeoung Kim ) (검색결과 187 건)
- 무료
- 기관 내 무료
- 유료
-
이민수,김용구,김영훈,연병길,오병훈,윤도준,윤진상,이철,정희연,강병조,김광수,김동언,김명정,김상훈,김희철,나철,노승호,민경준,박기창,박두병,백기청,백인호,손봉기,손진욱,양병환,양창국,우행원,이정호,이종범,이홍식,임기영,전태연,정영조,정영철,정인과,정인원,지익성,채정호,한상익,한선호,한진희,서광윤 大韓神經精神醫學會 1998 신경정신의학 Vol.37 No.1
연구목적 : 본 시험의 목적은 임상시험 시작전에 연구자들을 대상으로 PANSS Workshop을 통하여 PANSS, ESRS에 대한 국내에서의 표준화 작업을 구축하고 새로운 정신병 치료제인 리스페리돈의 효과와 안정성을 재확인하여 리스페리돈 사용에 대한 적정화를 이루는데 있다. 연구방법 : 1996년 4월부터 1996년 9월까지 국내 39개 대학병원 정신과에 입원중인 혹은 증상이 악화되어 입원하는 정신분열병 환자 377명을 대상으로 다시설 개방 연구를 시행하였다. 1주일간의 약물 배설기간을 가진후, 리스페리돈을 8주간 투여하였고, 기준점, 1주, 2주, 4주, 그리고 8주후에 평가되었다. 용량은 제1일에는 리스페리돈 1mg씩 1일 2회, 제2일에는 2mg씩 1일 2회, 제3∼7일에는 3mg씩 1일 2회 투여하였다. 이후 환자의 임상상태에 따라 임의로 증량할 수 있으며, 최대 일일 16mg을 초과하지 않도록 하였다. 추체외로 증상을 조절하기 위한 투약을 허용하였다. 임상증상 및 부작용의 평가는 PANSS(Positive and Negative Syndrome Scale), CGI(Clinical Global Impression) 그리고 ESRS(Extrapyramidal Symptom Rating Scale)을 사용하였다. 연구결과 : 377명중 343명(91%)이 8주간의 연구를 완결하였다. 치료 종결시점인 8주후 PANSS 총점수가 20% 이상 호전된 경우를 약물 반응군으로 정의할때, 약물반응군은 81.3%였다. 리스페리돈에 반응하는 예측인자로는 발병연령, 이전의 입원 횟수, 유병기간이 관련 있었다. 리스페리돈은 1주후부터 PANSS양성, 음성, 및 일반정신병리 점수상에 유의한 호전을 보여 효과가 빨랐다. CGI의 경우도 기준점에 비해 1주후부터 유의한 감소를 나타내었다. ESRS의 경우, 파킨슨 평가점수는 기준점과 비교해 투여 1주, 2주, 4주후 유의하게 증가되었다가 8주후 기준점과 차이가 없었다. Dystonia 평가점수는 1주후만 유의한 증가를 보였으며, dyskinesia 평가점수는 유의한 차이가 없었다. 혈압, 맥박수의 생명징후 및 일반 혈액학 검사, 생화학적 검사, 심전도 검사에서 유의한 변화는 없었다. 결 론 : 이상의 다시설 개방 임상 연구를 통해 리스페리돈은 정신분열병 환자에서 양성증상뿐만 아니라 음성증상 및 전반적인 증상에도 효과적인 것으로 사료된다. 보다 명확한 평가를 위해서는 다른 항정신병약물과의 이중맹검 연구가 필요할 것으로 생각되며, 또한 장기적 치료에 대한 평가도 함께 이루어져야 하겠다. Objective : The purpose of this study was to investigate the efficacy and safety of risperidone in the treatment of Korean schizophrenic patients. Method : This multicenter open study included 377 schizophrenic patients drawn from 39 university hospitals. After a wash-out period of 1 week, the schizophrenic patients were treated with risperidone for 8 weeks and evaluated at 5 points ; at baseline, and 1, 2, 4 and 8 weeks of treatment. The dose was increased from 2mg/day(1mg twice daily) to 6mg/day(3mg twice daily) during the first week and adjusted to a maximum of 16mg/day over the next 7 weeks according to the patient's clinical response. Medication to control extrapyramidal symptoms was permitted. The psychiatric and neurological status of the patients was assessed by PANSS, CGI, and ESRS scales. Results : 343(91%) of 377 patients completed the 8-week trial period. Clinical improvement, as defined by a 20% or more reduction in total PANSS score at end point, was shown by 81.3% of patients. The predictors of response to risperidone were associated older age, shorter duration of illness, fewer previous hospitalization. Risperidone had rapid onset of action ; a significant decrease of the total PANSS and three PANSS factor(positive, negative, general), and CGI was already noticed at the end of first week. For the ESRS, parkinsonism rating scores were significantly increased until week 4 comparing with baseline. Dystonia rating scores were significantly increased until week 1, and dyskinesia rating scores were not significantly changed during the study. Laboratory parameters including vital sign, EKG, hematological, and biochemical values showed no significant changes during the trial. Conclusions : This study suggests that risperidone is generally safe and effective against both the positive and negative symptoms in our group of patients.
-
김홍태,강도원,유찬훈,정재호,장세앙 대한척추외과학회 1996 대한척추외과학회지 Vol.3 No.1
The spinal fusion in a lumbar region may influence biomechanically in the remained mobile segment to take over the lost motions Therefore the stress concentration on the adjacent segments may accelerate the degenerative changes, and then various late changes could occur. The aim of this study was to evaluate the late changes occuring in the adjacent segments to lumbar fusions. A retrospective review of radiographs and medical records was undertaken for 67 consecutive patients who had undergone various fusions in the lumbar region for various pathologic conditions. Included in this study were the patients who had performed active daily livings without any significant pain or disability after fusion and followed for a minimum of five years(up to 18 years with a mean of 8.3 years). The results of this study were as follows : The instability, disc narrowing, spinal stenosis, vertebral slipping, or isthmic defect were found in the adjacent segments to fusions in the patients who were followed longer, in L4-5 segment and above segment of fusion, and in the adjacent segments where a degenerative changes existed before surgery and where the angular motion increased considerably in a few years after fusion. The symptoms of these patients were responded well with conservative theraphy and no patient needed any surgical theraphy during these follow-up periods.
-
김홍태,박봉훈,천동욱,김형표,정재호 대한척추외과학회 1995 대한척추외과학회지 Vol.2 No.1
A lumbar fusion may influence biomechanically on the remained unfused segments to take over the lost motions. The adjacent segments to fusion particulatly will experience an additional motional stress following a fusion, and then various late complications can occur. Moreover, the amount of this stress may differ according to the levels and extents of the fusions. The aim of this study is to evalu- ate this motional stress in different levels of fusion. A retrospective review of flexion and extension lateral radiograghs was undertaken for 142 consec- utive patients who had undergone various fusions in the lumbar region. Included in this study were the patients who had performed active daily livings after surgery and followed for minimum of two years. They were 60 males and 82 females, having mean age of 46.7(range 14-72). There were three posterior fusions, 123 lateral fusions, and 16 interbody fusions. The extent of fusions were one seg- ment in 71, two segments in 53, three segments in 16, and four segments in two patients. The follow- up period was 53 months in average(range 2-15 years). The intervertebral angles were measured on the flexion/extension lateral radiographs, and then the calculated intervertebral angular motions at follow-up periods were compared with those of preoperative values. The average increases of angular motion at the adjacent segments to fusions were 2.3˚at L1-2 seg- ment(ranging 0˚to 5˚increase),2.5˚at L2-3 segment(ranging 1˚decrease to 8˚increase), 2.9˚at L3-4 segment (ranging 3˚decrease to 12˚increase), 6.7˚at L4-5 segment(ranging 2˚to 18˚ increase), and 1.5˚at L5-S1 segment(ranging 5˚decrease to 7˚increase). The average increases of the above and below adjacent segments to fusions were 3.3˚(ranging 3˚decrease to 18˚increase) and 1.7˚(ranging 5˚decrease to 12˚increase) respectively. There were no significant differences in the changes of angular motion according to the extents of fusion and during these follow-up periods. In conclusion, the angular motions at the adjacent segment to fusions increased most signficantly at L4-5 segment regardless of the fusion sites whether it is below or above a fusion. Excluding the L4-5 segment, the angular motions at the above adjacent segments to fusion increased significantly compared to those at the below adjacent segments. The late complications at adjacent segments to lumbar fusions are expected to appear preferably at these segments.
-
한국어판 예일 틱 증상 평가척도 : 신뢰도 및 타당도 연구
정선주,이정섭,유태익,구영진,전성일,김봉석,홍강의 大韓神經精神醫學會 1998 신경정신의학 Vol.37 No.5
목 적 : 틱 증상의 심한 정도를 평가하기 위한 도구인 예일 틱 증상 평가척도(Yale Global Tic Severity Scale)를 한국판 가정 평가용 설문지 및 임상 평가용 척도로 개발하기 위하여 본 연구를 시행하였다. 방 법 : 예일 틱 증상 평가척도는 뚜렛 장애 및 기타 틱 장애에서 나타나는 운동틱과 음성틱 각각의 증상의 수, 빈도, 심한 정도, 복합성, 방해 정도 및 장해도를 포괄적으로 평가하도록 고안되어져 있다. 틱 증상을 주소로 정신과외래를 방문한 만 4.3세에서 19세까지의 100명의 환아 및 부모들을 대상으로 한국어로 번역한 예일 틱 증상 평가척도의 가정평가용 설문지를 평가전에 완료하도록 한 후, 면담을 통한 임상평가용 척도를 실시하였으며 수렴타당도 및 변별타당도의 검증을 위해 총괄적인 임상 인상척도-뚜렛 증후군, 강박장애, 주의력결립/과잉운동장애(Clinical Global Impression-TS, OCD, ADHD)를 시행하였다. 결 과 : 자료분석결과 내적일치도, 수렴타당도, 변별타당도 및 검사자간 신뢰도 모두 매우 높게 나타났으며 요인분석상 전 항목척도와 장해도는 운동틱과 음성틱에 해당하는 2개의 요인으로 묶여졌다. 결 론 : 본 연구결과 한국판 예일 틱 증상 평가척도의 높은 타당도 및 신뢰도가 입증되었으며 이는 향후 틱 증상의 객관적인 평가 및 정량화를 위해 유용하게 사용되어질 수 있을 것이다. Objectives : This study was carried out to develop the Korean form of Yale Global Tic Severity Scale(YGTSS)-family & clinical rating version. The severity of motor and phonic tics was rated according to five separate dimensions : number, frequency, intensity, complexity, and interference. Methods : The Korean form of YGTSS was applied to 100 children who visited psychiatric outpatient clinic with chief complaints of tic symptom. Together with YGTSS, Clinical Global Impression for Tourette's syndrome(CGI-TS), Obsessive-Compulsive disorder(CGI-OCD), Attention-Deficit/Hyperactivity Disorder(CGI-ADHD) were administered to all subjects for examining convergent and discriminant validities. Results : We could confirm high internal consistency, convergent and discriminant validities and interrater reliability of YGTSS by analysing data from 100 children with tic disorder. In factor analysis, items were clustered to 2 factors which were identical to motor and phonic tic subscales. Conclusion : The results of this study indicate the Korean form of YGSS is a reliable and valid rating scale for rating tic symptom severity. It can be used to evaluate tic symptom objectively and to quantify the tic severity in the studies for tic disorder.
-
-
( Hong Jeoung Kim ),( Jeong Youp Park ),( Seung Min Bang ),( Seung Woo Park ),( Yong Chan Lee ),( Si Young Song ) 대한소화기학회 2007 SIDDS Vol.9 No.-
Background/Aims: Recurred malignant obstructions after gastric cancer surgery are usually unsuitable for further surgical management. Endoscopic placement of self-expandable metallic stents (SEMS) has been used for palliative treatment of malignant obstruction at gastrointestinal tract. SEMS can be also useful for recurred malignant obstruction around the anastomosis site after gastroduodenal obstruction, but there only few reports about it. Methods: To evaluate technical success and clinical outcome for SEMS placement in patients with recurred malignant obstruction after surgery, 47 patients were included through medical record review. All patients had undergone gastrectomy for gastric cancer and had symptomatic obstruction around anastomotic site due to tumor recurrence from March 2002 to December 2006. Results: Technical success was achieved in 45 of 47 (95.7%) cases. During the follow-up of average 121 days (25-448), stent failure occurred in 14 patients (stent migration: 4; tumor overgrowth: 1; tumor ingrowth: 9 patients). Failure rates were not different according to operation or stent type. Stent failure occurred in 6 out of 25 cases (24.0%) with subtotal and 7 out of 23 cases (30.4%) with total gastrectomy, respectively. Stent failure was observed in 6 out of 22 cases (27.3%) and 7 out of 23 cases (30.4%) treated with covered and uncovered stents, respectively. A statistically signific ant improvement in overall GOOSS scores between pre- and post-procedure was noted (p<0.001). 43/47 patients (91.5%) showed improvement in their level of dietary intake. Improvement of oral intake was not different according to the operation type. Conclusions: The placement of SEMS is both technically feasible and effective mean for the palliation in patients with recurred malignant obstructions around the anatsomosis site after gastric cancer surgery. It is a safe alternative to surgery and advantage is minimal invasiveness. We advocate SEMS treatment it patients with recurred malignant obstruction to improve of quality of life.
-
Kim, Nam-Hee,Park, You-Mie,Jeong, Eun-Sook,Kim, Chang-Soo,Jeoung, Min-Kyo,Kim, Kyoung-Soon,Hong, Seung-Hwa,Son, Jong-Keun,Hong, Jin-Tae,Park, Il-Young,Moon, Dong-Cheul 대한약학회 2007 Archives of Pharmacal Research Vol.30 No.10
An immunoglobulin (IgG) preparation with micro-amount of histamine fixed on the active protein fraction has been used to increase the resistance to allergic reactions. However, excessive histamine may cause hypo- or hypertension, headache, or anaphylactic shock and so the histamine content of the drug is strictly controlled by a regulation: $0.15{\mu}g$ of histamine dihydrochloride is allowed for 12 mg of immunoglobulin. In this study, a liquid chromatographic method to determine micro-amount of histamine in the pharmaceutical was developed and validated. This method include a sample cleanup by a solid phase extraction (SPE) using a polystyrenedivinyl benzene (PS-DVB) polymeric sorbent and high-performance liquid chromatography after precolumn fluorescent labeling of the histamine with o-phthaldialdehyde. The drug sample was loaded to the SPE cartridge after adjusting to pH 9.5. After successive washings of the cartridge with water and 30% aqueous methanol, histamine was then eluted with 100 mM sodium acetate (pH 9.5)-methanol (20:80, v/v). An aliquot from the eluate was labeled with 0phthaldialdehyde-mercaptoethanol (OPA-ME) for fluorescence detection at the excitation maximum of 340 nm and emission maximum of 450 nm. HPLC analysis was performed on a phenyl-hexyl column with an acetonitrile-phosphate buffer (pH 6.8; $50{\mu}M$) (35:65, v/v) as the mobile phase. The retention times of histamine and 3-methylhistamine (IS) were approximately 7.2 and 9.5 min, respectively. The quantitation range was between 0.01-0.2 mg/mL of histamine showing good linearity (r=0.9996). This analytical method would provide a potential mean for the strict control of histamine content in the pharmaceutical product.
-
-
-
RISS
스콜라연관 검색어 추천
이 검색어로 많이 본 자료
활용도 높은 자료
